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ABSTRACT 24 
Periosteal expansion enhances bone strength and is controlled by osteogenic cells of the 25 
periosteum.  The extent of cellular periosteum at the human femoral neck, a clinically 26 
relevant site, is unclear.  This study was designed to histologically evaluate the human 27 
femoral neck periosteal surface.  Femoral neck samples from eleven male and female 28 
cadavers (ages 34-88) were histologically assessed and four periosteal surface 29 
classifications (cellular periosteum, mineralizing periosteum, cartilage, and mineralizing 30 
cartilage) were quantified.  Femoral mid-diaphysis samples from the same cadavers were 31 
used as within-specimen controls.  The femoral neck surface had significantly less (p < 32 
0.05) cellular periosteum (18.4 ± 9.7 %) compared to the femoral diaphysis (59.2 ± 13.8%).  33 
A significant amount of the femoral neck surface was covered by mineralizing periosteal 34 
tissue (20-70%).  These data may provide an alternate explanation for the apparent femoral 35 
neck periosteal expansion with age and suggest the efficiency of interventions that 36 
stimulate periosteal expansion may be reduced, albeit still possible, at the femoral neck of 37 
humans.  38 
 39 
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INTRODUCTION 48 
The risk of hip fracture increases exponentially with age (10).  Predictions for 49 
future trends in hip fractures are staggering, estimated at more than 6 million by 2050 (11), 50 
compared to 1.5 million in 1990 (12).  Hip fractures localized to the femoral neck present 51 
unique difficulties for treatment (6) and carry with them the highest rate of fracture-related 52 
morbidity (10).  Although the factors that lead to a femoral neck fracture are numerous, it is 53 
well-accepted that the structural geometry of the neck is significantly related to fracture 54 
risk.  55 
Periosteal expansion occurs throughout life.  The rate of expansion is high during 56 
the pubertal years (9), slower during the adult years (23, 25) and, in women, accelerated 57 
again after menopause (1).  This apposition is manifested through the cells of the periosteal 58 
cambium layer, which is in direct contact with the periosteal bone surface and contains a 59 
rich supply of osteogenic cells.  Independent of other changes, expansion of the periosteal 60 
surface increases the strength of long bones and decreases the risk of fracture (19).   61 
The existence of periosteum at the femoral neck is commonly debated.  Early 62 
observational (20, 21) and histological (4) studies suggest the human femoral neck lacks a 63 
periosteum.  The absence of callus formation following femoral neck fractures in adults 64 
supports these observations (20, 26).  Despite recent studies that suggest the absence of 65 
periosteum at the femoral neck is not absolute (3, 13, 22, 24), publications continue to state 66 
that the femoral neck lacks a periosteal covering (14-16).  If periosteum is to be a future 67 
therapeutic target to enhance bone strength (2) the extent of periosteum at this clinically 68 
relevant site must be clarified.  This study was designed to examine the periosteal surface 69 
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of the human femoral neck, through quantification of cellular periosteum and 70 
characterization of other types of surface coverings. 71 
METHODS 72 
Samples of femoral neck and femoral mid-diaphyseal tissue were obtained from eleven 73 
cadavers at the Indiana University School of Medicine (Table 1).  Cadavers were 74 
embalmed within 24-48 hours of death, thus preserving structural and cellular detail at that 75 
point.  Mid-diaphyseal tissue was used for an internal control for any possible changes in 76 
cell detail lost during the processing of tissue, as cellular periosteum is known to cover a 77 
substantial percentage of this surface (28).  Entire cross-sections of both femoral neck and 78 
mid-diaphyseal samples were divided into quadrants (four and two, respectively) to ease 79 
demineralization and sectioning processes.  Samples were demineralized in 5% formic acid 80 
buffered formalin, dehydrated in sequential ethanols, cleared with xylene, and embedded in 81 
paraffin for histological sectioning.  Serial transverse cross-sections (4 µm) were cut using 82 
a Reichert-Jung 2050 microtome (Magee Scientific, Inc., Dexter, MI) and stained with 83 
Massons trichrome.   84 
For all surfaces, one of four classifications was noted (Figure 1).  Cellular 85 
periosteum contained multiple cells (independent of cell morphology) within ~50 µm of the 86 
periosteal surface.  Cells did not have to be continuous along the surface yet multiple cells 87 
had to be present within a focal area (~50 µm of surface) to be counted.  Mineralized 88 
periosteum was in a similar spatial location to cellular periosteum (within ~50 µm of 89 
periosteal surface) although no cells were observed.  Rather mineralizing nodules/tissue 90 
lacked any lamellar pattern and were clearly distinct from the periosteal bone surface.  91 
Cartilage (hyaline) consisted of a blue stained matrix with abundant chondrocyte lacunae; 92 
  6 
(D) Mineralized cartilage (hyaline)  consisted of red stained matrix with islands of blue 93 
unmineralized cartilage surrounding chondrocyte lacunae.  Variable surface percentages in 94 
each specimen did not conform to any of the four criteria yet displayed no other discernable 95 
tissue patterns.  For each specimen, one entire cross section was analyzed from each 96 
location using a semiautomatic digitizing system (Bioquant System 4, R&M Biometrics, 97 
Inc., Nashville, TN) attached to a microscope with a bright-field light source (Nikon 98 
Optihot 2 microscope, Nikon, Tokyo, Japan).  The length of surface covered by each tissue 99 
classification is expressed as a percentage of total surface length.  Differences in periosteal 100 
surface tissue composition between femoral neck and diaphysis were compared using a 101 
Wilcoxon signed ranks test for matched samples; correlations between femoral neck 102 
surface tissues and age were assessed using Spearman rank order analysis.  Data are 103 
presented as percentage or mean ± SD.  For all tests, a p value of < 0.05 was deemed 104 
statistically significant.    105 
RESULTS 106 
Femoral mid-diaphyseal bone served as an adequate control tissue for periosteal 107 
assessment, having a cellular cambium layer on greater than 40% of the surface in all 108 
specimens (Figure 2 and 4A).  In sharp contrast, the femoral neck had significantly less 109 
cellular periosteum (18.4 ± 9.7 %) compared to the diaphysis, with individual subjects 110 
ranging from 2-33% (Figure 3A and 4A).  In all subjects the amount of cellular periosteum 111 
on the diaphysis was > 2 fold higher compared to the femoral neck.  The lower cellular 112 
periosteum surface percentage at the femoral neck compared to mid-diaphyseal bone are 113 
inversely associated with increased amounts of mineralized tissue (Figure 3B and 4B).  114 
Notably absent on diaphyseal bone, this mineralized tissue, which is distinctly discernable 115 
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histologically from lamellar bone, covers between 20-70% of the femoral neck surface 116 
(Figure 4B).  There was no cartilage covering any portion of the diaphyseal bone, while 117 
variable amounts of both mineralized and non-mineralized cartilage were quantified at the 118 
femoral neck (Table 2).  There was no significant correlation between subject age and the 119 
percent of cellular (R2 = 0.18) or mineralized (R2 = 0.07;) periosteum at the femoral neck 120 
(Figure 5).  Similarly, there was no correlation between age and cellular periosteum at the 121 
femoral diaphysis (R2 = 0.05). 122 
 123 
DISCUSSION 124 
The results of this study document that the human femoral neck has significantly less 125 
cellular periosteum than diaphyseal bone.  Unlike the diaphysis, the majority of the femoral 126 
neck periosteal surface is covered by mineralizing tissue located spatially where cellular 127 
periosteum would be expected.  The majority of studies that have addressed the issue of 128 
periosteum at the femoral neck have been qualitative (3, 4, 20, 21, 24, 27) and rarely define 129 
whether cellular periosteum exists at this location.  To our knowledge only one study (22) 130 
has quantitatively evaluated the human femoral neck; their measurement of cellular 131 
periosteum (16%) is comparable to the results of the current study (18.4%).  All subjects in 132 
this previous study (22) were over 75 years of age.  In the current study, which includes 133 
younger individuals, the 34, 42 and 49 year old subjects had < 32% of cellular periosteum 134 
covering the femoral neck surface.  This, along with the lack of correlation between age 135 
and cellular periosteum (Figure 5) suggests that periosteal cellularity at the femoral neck is 136 
significantly lower than in diaphyseal bone even in young adults.   137 
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Perhaps more striking than the lack of a cellular periosteum at the femoral neck was 138 
the large extent of mineralizing tissue (20-70% of surface).  There is precedent for such 139 
mineralizing tissue on the periosteal surface of other human bones (28), yet this is the first 140 
study to quantitate such tissue at the femoral neck.  Zagba-Mongalima observed that after 141 
the age of 48, “periosteal calcifications” on diaphyseal bone were evident in over 75% of 142 
the subjects and were characterized by dense calcified aggregates throughout the inner 143 
layer of the periosteum which are devoid of osteocyte lacunae (28).  The histological 144 
observations of the current study conform to this description (Figure 3B).  This tissue 145 
appears to be one of two types of mineralizing tissues that have been described near the 146 
periosteal surface (7, 8, 24, 27).  Calcified fibrocartilage exists at the femoral neck as early 147 
as age 20 and is observable using backscatter electron microscopy (7, 8, 24, 27), 148 
synchotron imaging (7, 8, 24, 27), and standard histology (7, 8, 24, 27).  Although we did 149 
not observe any calcified fibrocartilage (we noted mineralized hyaline cartilage) in the 150 
current study, others have documented both types of calcified tissue in a given specimen 151 
(27).  As only one cross-section from each location was assessed, we cannot discount the 152 
possibility that femoral neck surfaces may vary along the length of the femoral neck.  153 
However, previous studies provide no indication of such spatial differences with respect to 154 
various tissue types (24).   155 
These results have two main implications.  From the perspective of reducing 156 
femoral neck fractures, the fact that 20% of the femoral neck surface has cellular 157 
periosteum suggests that anabolic osteogenic therapies may be effective in strengthening 158 
this clinically relevant site.  As periosteal cells have greater sensitivity to mechanical (17) 159 
and pharmacological (18) stimuli compared to marrow cells, even limited cellular 160 
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periosteum may be sufficient for enhancing periosteal apposition.  These cells likely do 161 
serve to expand the periosteal diameter, as the femoral neck experiences age-associated 162 
radial expansion (5, 23, 25).  It may be, however, that the limited quantity of cells limits the 163 
rate of expansion, resulting in less than optimal bone geometry  and therefore elevated 164 
fracture risk.   165 
Alternatively, these data may present supporting evidence that the femoral neck 166 
exhibits an alternative means of periosteal apposition.  Previous studies have documented 167 
that both periosteal calcification and calcified fibrocartilage undergo osteonal remodeling 168 
(27, 28).  Although this study did not document any calcified fibrocartilage, the abundant 169 
periosteal mineralized tissue did contain individual osteons, clearly separate from the 170 
periosteal bone surface, in some regions.  Such a mechanism could be an alternative 171 
explanation for femoral neck periosteal expansion with age.  Thus, rather than 172 
circumferential lamellae being laid down on the periosteal surface and subsequently 173 
remodeled into osteons, as occurs in diaphyseal bone, mineral accumulates separate from 174 
the periosteal surface with subsequent osteonal remodeling necessary for incorporation into 175 
the existing bone.  The highly irregular surface of the femoral neck, as compared to the 176 
relatively smooth periosteal surface of diaphyseal bone, certainly supports this hypothesis 177 
although further study is necessary.   178 
Our data document that the human femoral neck has significantly less surface 179 
covered by cellular periosteum than the femoral diaphysis.  Such differences appear to 180 
manifest during the early adult years and exist in both genders.  It remains unclear whether 181 
periosteal apposition at the femoral neck is mediated through the limited number of 182 
periosteal cells or if alternate means of expansion (soft tissue mineralization followed by 183 
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remodeling) exist.  From a clinical perspective, the relatively sparse cellular periosteum on 184 
the femoral neck may reduce the efficacy of interventions (both pharmacological and 185 
mechanical) that stimulate periosteal apposition at this site.   186 
187 
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Figure Legends 187 
Figure 1:  Periosteal surface tissue classifications.  In each image, the periosteal surface 188 
(P) is noted.  (A) Cellular periosteum contained multiple cells (independent of cell 189 
morphology) within ~50 µm of the periosteal surface.  Cells did not have to be continuous 190 
along the surface yet multiple cells had to be present within a focal area (~50 µm of 191 
surface) to be counted.  Original magnification x 200, bar = 50µm; (B) Mineralized 192 
periosteum was in a similar spatial location to cellular periosteum (within ~50 µm of 193 
periosteal surface) although no cells were observed.  Rather mineralizing nodules/tissue 194 
lacked any lamellar pattern and were clearly distinct from the periosteal bone surface.  195 
Original magnification x 100, bar = 100µm; (C) Cartilage (hyaline) consisted of a blue 196 
stained matrix with abundant chondrocyte lacunae.  Original magnification x 100; bar = 197 
100µm; (D) Mineralized cartilage (hyaline)  consisted of red stained matrix with islands of 198 
blue unmineralized cartilage surrounding chondrocyte lacunae.  Original magnification x 199 
200, bar = 50µm.  All sections stained with Massons trichrome. 200 
 201 
Figure 2:  Photomicrographs of femoral diaphysis periosteal surface.   Cellular periosteum 202 
(arrowheads) is clearly observed near the periosteal surface.  Section is from an 81 year-old 203 
female cadaver stained with Massons trichrome.  Original magnification x 200, bar = 204 
50µm. 205 
 206 
Figure 3:  Photomicrographs of femoral neck periosteal surface.   Cellular periosteum (A) 207 
and mineralizing periosteum (B) are clearly observed near the periosteal surface.  208 
Mineralizing periosteum is noted directly near (arrows) the bone surface.  Sections are 209 
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from an 81 year-old female cadaver stained with Massons trichrome.  A: Original 210 
magnification x 200, bar = 50µm.  B: Original magnification x 40, bar = 100µm. 211 
 212 
Figure 4:  Quantification of cellular (A) and mineralizing (B) periosteum at the femoral 213 
neck and mid-diaphysis.  Data presented as the percent of total periosteal surface covered 214 
by each tissue type.  * significantly different (p < 0.01) compared to alternate site.  215 
 216 
Figure 5:  Correlation between age and periosteal tissue type at the femoral neck.  There 217 
was no significant relationship between age and either cellular or mineralizing periosteum. 218 
219 
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Table 1:  Specimen characteristics 222 
Gender Age Cause of death 
Female 34 Renal carcinoma 
Female 42 Breast carcinoma 
Male 49 Lung carcinoma 
Female 66 Metastatic carcinoma 
Male 68 Aortic aneurysm 
Male 70 Cardiac arrhythmia 
Female 75 Lung carcinoma 
Female 76 Congestive heart failure 
Male 77 Renal disease 
Female 81 Lung carcinoma 
Female 88 Lung carcinoma 
 223 
 224 
225 
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Table 2:  Cartilage surface on femoral neck 225 
Subject Age Cartilage 
surface, % 
Mineralized 
cartilage surface, % 
Female 34 1.63 0.55 
Female 42 9.89 6.91 
Male 49 0.00 15.78 
Female 66 4.13 1.12 
Male 68 0.00 0.00 
Male 70 3.33 0.52 
Male 77 17.95 4.80 
Female 81 1.29 0.00 
Male 81 12.50 15.71 
Female 88 1.62 0.00 
 226 
 227 
 228 
Data are expressed as the percentage of the femoral neck periosteal surface covered by 229 
each tissue type.  There was no cartilage tissue on the periosteal surface of mid-diaphyseal 230 
bone. 231 
 232 
233 
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Figure 5 378 
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